{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-246082","form_type":"8-K","ticker":"IBRX","cik":"0001326110","company_name":"ImmunityBio, Inc.","filed_at":"2021-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.670881+00:00","generated_at":"2026-06-29T11:07:40.134047+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ImmunityBio appoints Patrick Soon-Shiong as Global Chief Scientific and Medical Officer; base salary $600k","bullets":["Dr. Patrick Soon-Shiong appointed as Global Chief Scientific and Medical Officer, a new executive position, effective Aug 11, 2021.","Soon-Shiong will also continue as Executive Chairman; receives base salary of $600k/year and bonus up to 50% of salary.","CFO David Sachs gets base salary increase from $397k to $475k, effective next payroll period."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-246082","json":"https://secwatch.observer/filing/0001193125-21-246082.json","markdown":"https://secwatch.observer/filing/0001193125-21-246082.md","text":"https://secwatch.observer/filing/0001193125-21-246082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326110/000119312521246082/0001193125-21-246082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326110/000119312521246082/d218269d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T11:07:40.134047+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"44ede58108","claim":"Patrick Soon-Shiong was appointed as Global Chief Scientific and Medical Officer at ImmunityBio, Inc..","evidence_excerpt":"appointed Patrick Soon-Shiong, M.D., as Global Chief Scientific and Medical Officer of the Company, a newly created executive position, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326110/000119312521246082/0001193125-21-246082-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Global Chief Scientific and Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}